Monte Rosa Therapeutics, Inc. (GLUE)

14.31 +0.37 (+2.65%) USD  |  NASDAQ  |  Sep 01, 16:00
14.31 0.00 (0.00%) After-Hours: 17:19
More

Monte Rosa Therapeutics Cash and Short Term Investments (Quarterly) : 621.10M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 621.10M
March 31, 2026 666.22M
December 31, 2025 377.10M
September 30, 2025 391.26M
June 30, 2025 290.59M
March 31, 2025 326.07M
December 31, 2024 372.15M
September 30, 2024 242.19M
June 30, 2024 262.20M
March 31, 2024 192.89M
December 31, 2023 232.41M
September 30, 2023 178.48M
Date Value
June 30, 2023 203.07M
March 31, 2023 232.69M
December 31, 2022 263.79M
September 30, 2022 273.11M
June 30, 2022 294.14M
March 31, 2022 317.16M
December 31, 2021 346.07M
September 30, 2021 367.03M
June 30, 2021 357.06M
March 31, 2021 168.44M
December 31, 2020 41.70M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Nurix Therapeutics, Inc. 443.53M
Gilead Sciences, Inc. 4.882B
Ironwood Pharmaceuticals, Inc. 79.13M
Capricor Therapeutics, Inc. 237.93M
Cue Biopharma, Inc. 17.39M